Nitro derivatives of five-membered heterocyles are of considerable interest. Some are biologically active with anti-inflammatory or vasodilatory activity (1). The 5-nitroimidazoles are used as antiamoebic, antiprotozoal and antibacterial agents. Two important members of this chemical class are metronidazole and tinidazole. Discovery of the anti-trichomonal properties of metronidazole revolutionized the treatment of disease. A new approach to the spectrophotometric determination of metronidazole (MZ) and tinidazole (TZ) has been developed. The procedure involves coupling of diazotized nitroimidazoles with p-dimethylaminobenzaldehyde (DMAB) to form a greenish-yellow solution. Optimal temperature and time were 0°C (iced) and 3 minutes for diazotization and 30°C and 2 minutes for coupling for both MZ and TZ. Coloured adducts of MZ and TZ showed shoulders at 406 nm and 404 nm, respectively, which were selected as analytical wavelengths. The reaction with p-DMAB occurred in a 1:1 mole ratio. Beer's law was obeyed within the 4.8-76.8 mg mL -1 concentration range with low limits of detection. The azo adducts were stable for over a week. Molar absorptivities were 1.101 0 3 (MZ) and 1.30´10 3 L mol -1 cm -1 (TZ). Overall recoveries of MZ and TZ from quality control samples were 103.2 ± 1.3 and 101.9 ± 1.3 % over three days. There was no interference from commonly utilized tablet excipients. No significant difference was obtained between the results of the new method and the BP titrimetric procedures. The azo approach using the p-dimethylaminobenzaldehyde procedure described in this paper is simple, fast, accurate and precise. It is the first application of DMAB as a coupling component in the diazo coupling reaction.
ducing agent was incubated at appropriate temperature and the progress of reduction was assessed at 5-minute intervals. The optimum time required for the reduction process to go to completion was determined through the formation of salmon-pink colour with DMAB, indicating the conversion of the nitro group to amine.
General procedure
A 5-mL volume of 7´10 -3 mol L -1 solution of the reduced MZ or TZ solution (reduced with LiBH 4 in methanol) was transferred to a 50-mL calibrated beaker, 5 mL of 0.1 mol L -1 NaNO 2 solution was added and the mixture was stirred for 2 min. Then 5 mL of 0.2 mol L -1 sulfamic acid solution was added and stirred again for 1 min, all at 0°C (iced). Diazotized solutions were freshly prepared each day. Sample solutions for spot tests and TLC were prepared by mixing 1.0 mL of the DMAB solution and 1 mL of the diazotized drug. The colours obtained were recorded immediately and after 20 min. Solutions of these azo adducts and that of DMAB were kept in a water bath (80°C) and examined after 20 min.
The analytical wavelength was selected by recording the spectra of DMAB, the reaction products with MZ and TZ as well as the spectra of diazotized MZ and TZ. The spectra were overlaid on each other and the analytical wavelength was selected by inspection.
Temperature and time optimization was done using the method of steepest ascent (18) . This was carried out at 30, 50, 60 and 80°C, after 5 and 20 minutes each. Eight test tubes each containing 0.5 mL of 0.12 % (7´10 -3 mol L -1 ) of reduced and diazotized metronidazole (MZ) was used. p-DMAB solution (0.5 mL 0.1 %) was added to each of the test tubes and vortexed. Methanol (4 mL) was added to each of the tubes to make up to 5 mL of reaction volume. At the end of the various reaction times and temperatures, the absorbance reading of each of the mixtures was taken at 406 nm with methanol as blank solvent. The same procedures were repeated for reduced and diazotized tinidazole (TZ) at 404 nm. Optimization of the time required for coupling to take place at room temperature (30°C) was done at 0, 2, 5, 10, 20 and 30 minutes. The reaction mixtures were made up to 5 mL at these times with methanol, and the absorbance readings were taken at 406 nm and 404 nm (MZ and TZ, respectively) with methanol as blank.
The analytical signal stability was assessed by measuring the absorbance of the adducts at the working wavelengths at 5-minute intervals for the first 30 min, at 30-minute intervals for the next three hours and then daily for 7 days.
Stoichiometric ratio determination
Job's method of continuous variation (19) was used to determine the stoichiometric ratios at which the diazotized imidazoles combine with DMAB. Various volumes of diazotized solution of MZ/TZ were made up to 1.0 mL with the DMAB solution. The tubes were kept at 30°C for 2 min. At the end of the reaction time, methanol was added. The absorbance readings were taken at 406 nm for MZ and at 404 nm for diazotized TZ. Blank values were subtracted from that of the reaction mixture. All procedures were carried in duplicate.
Validation studies
Calibration curves were prepared using concentrations of diazotized MZ and TZ of 0, 4.8, 9.6, 19.2, 38.4 and 76.8 (0, 2.8, 5.6, 11.2, 22.4, 44.8´10 -5 mol L -1 and 0, 1.9, 3.9, 7.8, 15.5, 31.1´10 -5 mol L -1 , respectively). 0.5 mL of 0.1 % (m/V) p-DMAB was added to each of the tubes. These were allowed to stand for 2 minutes after which respective volumes of methanol were added to make up to 5 mL of the reaction mixture. The absorbance readings of each mixture were recorded at 406 and 404 nm, respectively.
The limit of detection (DL) and limits of quantitation (QL) were calculated according to the current ICH guidelines (20) as 3.3 and 10 standard deviation of the blank (n = 6) divided by the slope of the calibration curve. Model recoveries and repeatability of the new methods were carried out on three successive days as stipulated by the USP (21) . Accuracy was estimated at three concentration levels and 95 % confidence limits.
To study the potential interference from the commonly utilized tablet excipients and other additives such as starch, lactose, magnesium stearate, talc, gelatin and their mixtures, recovery studies of 38.4 mg mL -1 (0.224 mmol L -1 and 0.155 mmol L -1 , respectively) metronidazole and tinidazole from the matrices containing these excipients were carried out. Four replicates were analyzed for each drug.
Assay of dosage forms
Three different brands of metronidazole tablets, one brand of infusion and one brand of tinidazole tablets were analyzed. Mass uniformity test was carried out on the different brands, and the active ingredient assay was then carried out based on the new method for each brand.
An amount of powdered tablets equivalent to 0.03 g of metronidazole and tinidazole was reduced with LiBH 4 and then diazotized. A 0.16-mL aliquot of each of the respective reduced and diazotized MZ and TZ stock solution (equivalent to 0.036 mmol MZ and 0.025 mmol TZ) was then transferred into test tubes. 0.5 mL of 0.1 % p-DMAB was added to each of the tubes. The reaction was allowed to proceed for 2 min after which methanol (4 mL) was added. For MZ infusion, 6 mL of infusion solution was reduced and diazotized and 0.16 mL of the diazotized stock was used for coupling. The absorbance reading of the respective reaction mixtures was recorded at 406 nm and 404 nm, respectively, for MZ and TZ using methanol as blank solvent. Official non-aqueous titration (4) was adopted for MZ and TZ tablets and the UV spectrophotometric method was used for the MZ infusion at 277 nm. Six replicate determinations were carried out in each case.
RESULTS AND DISCUSSION

Chemistry
Metal hydrides were found to give the best results for the formation of the azo adduct between diazotized nitroimidazoles and DMAB among the reducing agents studied. A persistent yellowish-green colour was produced and was stable for seven days. This col-our is completely different from the salmon-pink produced after condensation reaction between reduced nitroimidazoles and DMAB (16) . This is the first paper to report the use of DMAB as a coupling reagent in acidic solution. Since the dimethylamino moiety in DMAB has a moderate activating influence on the aromatic skeleton, ortho substitution of an incoming electrophile might be possible. This reaction will be further aided by the presence of the aldehyde group which is meta-directing. Thus the 3-and 5-positions on the DMAB molecule are equivalent and will be available for electrophilic attack. This was found true. This is illustrated in Scheme 1 showing the coupling of diazotized imidazoles with DMAB. Fig. 1 presents the structures of the new compounds produced between DMAB and MZ and TZ. The possibility of steric hindrance on substitution by diazotized nitroimidazoles is eliminated as the dimethylamino group is staggered from the diazo linkage (bond angle between N8, C14 and C12 for the TZ adduct is 120.456°a nd that of the MZ adduct between N 18, C 10 and C 4 is 122.665°). This shows that the angles around a main chain nitrogen atom (the diazo linkage) are all approximately equal to 120 degrees: consequently, the group is planar. Likewise, the torsion angles are 0.94 and 0.339°, respectively, for the TZ-DMAB and MZ-DMAB adducts. Since the torsion is between 0 and +90°, the stereochemical arrangement is of the syn type. Both molecules are therefore of the trigonal planar skeleton. Both the bond and torsion angles favour the formation of a stable adduct.
Thin layer chromatographic analyses using normal phase revealed the formation of new adducts distinct from both DMAB and diazotized nitroimidazoles. The result of the TLC analysis is presented in Table I . In both mobile phases adopted, the adducts were more non-polar than the starting materials. This is expected, since conjugation of the benzene ring with imidazoles should yield compounds with reduced polarity.
The overlaid absorption spectra of the drugs, DMAB and the new adducts are presented in Figs. 2a and b, respectively, for MZ and TZ. Coupling reaction of reduced and diazotized nitroimidazoles with p-DMAB gave an instant greenish-yellow colour, indi- 
Optimization studies
Optimization of reducing agents revealed the superiority of metal hydrides over the dissolving metals in glacial acid. The metal hydrides were used at room temperature as compared to the use of elevated temperatures typical of Zn and Pd/C in ethanol or glacial acetic acid reported by previous methods of Ahmed and Onah (9), Rehamn et al. (10) and Siddappa et al. (16) . Reduction was completed in 5 min using LiBH 4 . This is one of the advantages of this report, which provides convenience of analysis.
The optimum coupling temperature and time for the coupling of diazotized MZ and TZ with p-DMAB were established as 30°C (room temperature) and 2 minutes. Higher 
CHO (a) DMAB-MZ adduct (b) DMAB-TZ adduct
Step I: Reduction
Step III: Coupling reaction The study of analytical signal stability for the two azo adducts at 404 and 406 nm revealed that absorbance was independent of time. The absorbance was constant over a period of seven days, when measured daily, with a loss of only about 7.4 % for the MZ adduct and 6.5 % for the TZ adduct.
The effect of water and methanol as diluting solvents was investigated after the coupling reaction. When methanol was used as solvent, higher absorbance readings, better regression equations, higher correlation coefficient and coefficient of determination were obtained compared to the values when water was used. This ability of methanol to cause high absorbance readings can be easily explained. The two processes leading to the coupling reaction, reduction and diazotization involve removal of water molecules; hence, any solvent that can sequester water molecules will favour the forward reaction, which will also bring about the formation of more complex molecules. Thus, methanol was chosen as the diluting solvent. It is also possible that the internal mesomeric effect within the carbonyl group on the DMAB molecule might be active in water and might cause some deactivation on the DMAB molecule. This reduces the possibility of coupling reaction taking place. However, the polar effect is eliminated in methanol and the strong activating influence of the dimethylamino fragment is optimal on thereby favouring the coupling reaction.
Optimal detector response was obtained when the diazotized nitroimidazoles combined at a mole ratio of 1:1 with DMAB as the coupling component. This corroborates the TLC result and hence the structure presented in Scheme 1 is justified.
Validation
The new approach produced excellent correlation for the regression of absorbance of the complex on the concentration of MZ (R 2 = 0.9980) and TZ (R 2 = 0.9983). Molar absorptivities were 1.1´10 3 L mol -1 cm -1 and 1.3´10 3 L mol -1 cm -1 and limits of detec- Table III . Table IV contains the intra-day assessment of the accuracy and precision of the new method for the assay of nitroimidazoles. The mean recovery of the new method when compared to the official method is presented in recoveries obtained for MZ and TZ, respectively, in the presence of excipients are in the order of 100.5-104.4 %. The results are presented in Table V . This lack of interference from tablet excipients is another advantage of this new method.
Application of the new method
The applicability of the new method described in this report for the assay of metronidazole infusion and tablets as well as tinidazole in tablets was examined and the results obtained were statistically compared with the official methods using F-ratio test, t-test, confidence limits and ANOVA. The results are presented in 
CONCLUSIONS
The new approach of utilizing p-dimethylaminobenzaldehyde as a coupling component is the first of such reports. The method adopted for the determination of nitroimidazoles (metronidazole and tinidazole) is simple, accurate, sensitive, and less time-consuming and free from extreme experimental conditions such as heating at high temperatures. It was successfully adopted for the analysis of these drugs in dosage forms. Some obvious advantages of this new approach to the determination of nitro-imidazoles include simplicity, accuracy, low cost and speed. Even though the method is a two-step approach, it compared favourably with other previously reported methods.
